Concepedia

Elodie Renaude

ER

Statistics

Publications

4

Citations

121

H-Index

4

Active since

2020

Affiliations

Inserm(Current)

Université Bourgogne Franche-Comté

Centre Hospitalier Universitaire de Besançon

Elodie Renaude is an author at Inserm specializing in oncology, cancer immunotherapy, and immunology.

ORCID

Publications per year

2020–2023

4

Publications

4

Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases

Marie Kroemer, Célia Turco, Laurie Spehner et al. · Journal for ImmunoTherapy of Cancer · 2020 · 36 citations · Full text

, , +17

Chemokine switch regulated by TGF-β1 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapy

Angélique Vienot, Jean‐René Pallandre, Elodie Renaude et al. · OncoImmunology · 2022 · 34 citations · Full text

, , +17

SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer

Rafael S. Martinez, Mark J. Salji, Linda Rushworth et al. · Cancer Research · 2021 · 29 citations · Full text

, , +17

CD8+ CD226high T cells in liver metastases dictate the prognosis of colorectal cancer patients treated with chemotherapy and radical surgery

Julien Viot, Syrine Abdeljaoued, Angélique Vienot et al. · Cellular and Molecular Immunology · 2023 · 22 citations · Full text

, , +17

1–4 of 4